Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
110.50
-0.36 (-0.32%)
At close: Nov 21, 2024, 4:00 PM
110.98
+0.48 (0.43%)
After-hours: Nov 21, 2024, 4:44 PM EST

Sarepta Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
10,5559,02111,3757,84113,4549,619
Upgrade
Market Cap Growth
5.33%-20.70%45.06%-41.72%39.87%25.01%
Upgrade
Enterprise Value
10,7718,67710,9077,42012,4229,064
Upgrade
Last Close Price
110.5096.43129.5890.05170.49129.04
Upgrade
PS Ratio
6.537.2612.1911.1724.9125.26
Upgrade
PB Ratio
8.6410.5029.558.4517.6611.76
Upgrade
P/TBV Ratio
9.9810.8730.148.5817.9811.94
Upgrade
P/FCF Ratio
----532.53-
Upgrade
P/OCF Ratio
----125.19-
Upgrade
EV/Sales Ratio
6.576.9811.6910.5723.0023.80
Upgrade
EV/FCF Ratio
----491.69-
Upgrade
Debt / Equity Ratio
1.161.634.201.231.410.89
Upgrade
Debt / FCF Ratio
----42.47-
Upgrade
Asset Turnover
0.490.390.300.230.220.22
Upgrade
Inventory Turnover
2.553.905.214.123.904.16
Upgrade
Quick Ratio
2.453.243.635.054.994.60
Upgrade
Current Ratio
3.843.954.135.755.975.55
Upgrade
Return on Equity (ROE)
12.27%-86.15%-107.16%-49.57%-70.15%-77.29%
Upgrade
Return on Assets (ROA)
1.51%-5.24%-10.68%-9.04%-14.67%-18.84%
Upgrade
Return on Capital (ROIC)
2.11%-7.86%-16.47%-14.21%-20.85%-21.75%
Upgrade
Earnings Yield
1.15%-5.94%-6.18%-5.34%-4.12%-7.43%
Upgrade
FCF Yield
-4.46%-6.40%-3.13%-6.14%0.19%-5.37%
Upgrade
Buyback Yield / Dilution
-13.80%-5.53%-7.75%-4.24%-5.90%-11.12%
Upgrade
Total Shareholder Return
-13.80%-5.53%-7.75%-4.24%-5.90%-11.12%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.